Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GC6101A in Gastritis
NCT02353039Phase 2Unknown
- Sponsor
- GC Biopharma
- Start
- Sep 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GC6101A in gastritis (4 arms), sponsored by GC Biopharma. Primary endpoint: Percentage of subjects showing moderate improvement of stomach erosions by endoscopy at 2 weeks. Status: unknown.
02
Drugs
GC6101A
03
Conditions
gastritis
Beyond the preview
Go deeper on NCT02353039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02353039.